FR2568892B1 - Nouvel antibiotique sandramycine, procede de preparation de celui-ci, culture biologiquement pure du micro-organisme nocardioides sp, atcc no 39419, et composition pharmaceutique contenant la sandramycine - Google Patents

Nouvel antibiotique sandramycine, procede de preparation de celui-ci, culture biologiquement pure du micro-organisme nocardioides sp, atcc no 39419, et composition pharmaceutique contenant la sandramycine

Info

Publication number
FR2568892B1
FR2568892B1 FR858509170A FR8509170A FR2568892B1 FR 2568892 B1 FR2568892 B1 FR 2568892B1 FR 858509170 A FR858509170 A FR 858509170A FR 8509170 A FR8509170 A FR 8509170A FR 2568892 B1 FR2568892 B1 FR 2568892B1
Authority
FR
France
Prior art keywords
sandramycin
nocardioides
atcc
antibiotic
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR858509170A
Other languages
English (en)
Other versions
FR2568892A1 (fr
Inventor
James A Matson
James A Bush
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FR2568892A1 publication Critical patent/FR2568892A1/fr
Application granted granted Critical
Publication of FR2568892B1 publication Critical patent/FR2568892B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
FR858509170A 1984-06-18 1985-06-17 Nouvel antibiotique sandramycine, procede de preparation de celui-ci, culture biologiquement pure du micro-organisme nocardioides sp, atcc no 39419, et composition pharmaceutique contenant la sandramycine Expired - Fee Related FR2568892B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/621,641 US4582639A (en) 1984-06-18 1984-06-18 Antitumor antibiotic compound

Publications (2)

Publication Number Publication Date
FR2568892A1 FR2568892A1 (fr) 1986-02-14
FR2568892B1 true FR2568892B1 (fr) 1990-02-09

Family

ID=24491001

Family Applications (1)

Application Number Title Priority Date Filing Date
FR858509170A Expired - Fee Related FR2568892B1 (fr) 1984-06-18 1985-06-17 Nouvel antibiotique sandramycine, procede de preparation de celui-ci, culture biologiquement pure du micro-organisme nocardioides sp, atcc no 39419, et composition pharmaceutique contenant la sandramycine

Country Status (23)

Country Link
US (1) US4582639A (fr)
JP (1) JPS6122099A (fr)
KR (1) KR930003107B1 (fr)
AT (1) AT395860B (fr)
AU (1) AU584075B2 (fr)
BE (1) BE902670A (fr)
CA (1) CA1230568A (fr)
CH (1) CH668974A5 (fr)
DE (1) DE3521436A1 (fr)
DK (1) DK272985A (fr)
ES (1) ES8609485A1 (fr)
FI (1) FI80475C (fr)
FR (1) FR2568892B1 (fr)
GB (1) GB2160529B (fr)
GR (1) GR851452B (fr)
IE (1) IE58629B1 (fr)
IT (1) IT1191622B (fr)
LU (1) LU85953A1 (fr)
MY (1) MY100478A (fr)
NL (1) NL8501708A (fr)
PT (1) PT80656B (fr)
SE (1) SE464524B (fr)
ZA (1) ZA852370B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902781A (en) * 1987-11-24 1990-02-20 Taisho Pharmaceutical Co., Ltd. Novel tripetide derivatives
DE3832362A1 (de) * 1988-09-23 1990-03-29 Sandoz Ag Neue cyclopeptolide, verfahren zu ihrer herstellung und ihre verwendung
US5523219A (en) * 1993-06-15 1996-06-04 Bristol-Myers Squibb Company Enzymatic hydrolysis method for the preparation of C-10 hydroxyl-bearing taxanes and enzymatic esterification method for the preparation of C-10 acyloxy-bearing
US5516676A (en) * 1993-06-15 1996-05-14 Bristol-Myers Squibb Company Preparation of C-13 hydroxyl-bearing taxanes using nocardioides or a hydrolase isolated therefrom
US5643871A (en) * 1993-11-23 1997-07-01 Bristol-Meyers Squibb Company Antitumor antibiotics
US5444043A (en) * 1994-02-18 1995-08-22 The Regents Of The University Of California Cyclic heptapeptide anti-inflammatory agent
GB2294265A (en) * 1994-10-20 1996-04-24 Merck & Co Inc Cyclic depsipeptides obtained from Actinomycete sp.
AU738864B2 (en) * 1997-03-28 2001-09-27 Scripps Research Institute, The Sandramycin analogs
US6001815A (en) * 1997-12-25 1999-12-14 Nisshin Flour Milling Co., Ltd. Depsipeptides containing N-substituted glycine residue
KR100575681B1 (ko) 2004-05-18 2006-05-03 엘지전자 주식회사 와인 냉장고의 진동절연 지지장치
WO2007024574A2 (fr) * 2005-08-19 2007-03-01 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Formulations topiques d'inhibiteurs d'histone desacetylase et procedes d'utilisation de celles-ci

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451456A (en) * 1979-04-02 1984-05-29 Bristol-Myers Company Antitumor antibacterial agents
US4360458A (en) * 1979-04-02 1982-11-23 Bristol-Myers Company Antitumor antibacterial agents

Also Published As

Publication number Publication date
DE3521436A1 (de) 1985-12-19
ES8609485A1 (es) 1986-09-01
FI80475C (fi) 1990-06-11
FR2568892A1 (fr) 1986-02-14
KR860000382A (ko) 1986-01-28
SE8502996L (sv) 1985-12-19
CH668974A5 (de) 1989-02-15
AT395860B (de) 1993-03-25
KR930003107B1 (ko) 1993-04-19
SE464524B (sv) 1991-05-06
MY100478A (en) 1990-10-15
IT1191622B (it) 1988-03-23
PT80656A (en) 1985-07-01
ZA852370B (en) 1985-11-27
AU4048085A (en) 1986-01-02
GB2160529B (en) 1987-10-07
IE58629B1 (en) 1993-10-20
CA1230568A (fr) 1987-12-22
SE8502996D0 (sv) 1985-06-17
FI852082L (fi) 1985-12-19
IT8521156A0 (it) 1985-06-14
BE902670A (fr) 1985-12-17
FI80475B (fi) 1990-02-28
GB2160529A (en) 1985-12-24
DE3521436C2 (fr) 1993-08-05
JPS6122099A (ja) 1986-01-30
DK272985A (da) 1985-12-19
JPH0158200B2 (fr) 1989-12-11
GB8515256D0 (en) 1985-07-17
DK272985D0 (da) 1985-06-17
US4582639A (en) 1986-04-15
ES544289A0 (es) 1986-09-01
LU85953A1 (fr) 1986-01-24
FI852082A0 (fi) 1985-05-24
PT80656B (pt) 1988-01-22
ATA178285A (de) 1992-08-15
GR851452B (fr) 1985-11-25
AU584075B2 (en) 1989-05-18
NL8501708A (nl) 1986-01-16
IE851504L (en) 1985-12-18

Similar Documents

Publication Publication Date Title
FR2505835B1 (fr) Nouvelles 1,2-diaminocyclobutene-3,4-diones, leur procede de preparation et composition pharmaceutique les contenant
FR2569402B1 (fr) Derives d'acide 3,5-pyridine-dicarboxylique, procede pour leur preparation et composition pharmaceutique les contenant
PT78340A (fr) Procede de preparation de nouveaux derives de la tetrahydroxy- 3',4',5,7-flavone et des compositions pharmaceutiques les contenant
FI874082A (fi) Menetelmä glykopeptidiantibioottien valmistamiseksi ja niitä tuottavia mikro-organismiviljelmiä
FR2531087B1 (fr) Nouvelle forme d'ester de cefuroxime, procede pour sa preparation et composition pharmaceutique la contenant
FR2591597B1 (fr) Comprime pharmaceutique enrobe contenant de l'ester 1-acetoxyethylique de la cefuroxime et procede de preparation de celui-ci
FR2567131B1 (fr) Nouveaux derives de ganglioside, procede pour leur obtention et composition pharmaceutique les contenant
IT8168566A0 (it) Complesso antibiotico procedimento per la sua preparazione composizione farmaceutica contenente tale complesso e microorganismo per l attuazione di tale procedimento
BE880584A (fr) Nouveaux derives d'imidazole, leur procede de production et composition pharmaceutique les contenant
IE850912L (en) 9a-AZA-9a HOMOERYTHROMYCIN DERIVATIVES.
FR2495154B1 (fr) 5'-aminoalkyl-4', 4, 8-trialkylpsoralenes, leur procede de production et composition pharmaceutique les contenant
FR2568892B1 (fr) Nouvel antibiotique sandramycine, procede de preparation de celui-ci, culture biologiquement pure du micro-organisme nocardioides sp, atcc no 39419, et composition pharmaceutique contenant la sandramycine
LU78330A1 (fr) Procede de preparation de nouveaux derives d'hydantoine et de composition pharmaceutique les contenant
FR2569702B1 (fr) Nouvelle 4'-deschlororebeccamycine, composition pharmaceutique la contenant et procede pour sa preparation
FR2567519B1 (fr) Nouvelles isoindolinyl-alcoyl-piperazines, compositions pharmaceutiques les contenant, et leur procede de preparation
FR2598420B1 (fr) Nouveaux esters retinoiques d'antibiotiques, leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
FR2594847B1 (fr) Procede de preparation de polypeptides biologiquement actifs, polypeptides obtenus et compositions les contenant
DK347788A (da) Teicoplaninlignende forbindelser, fremgangsmaade og mikroorganisme til fremstilling deraf og farmaceutisk praeparat indeholdende saadanne forbindelser
FR2600061B1 (fr) Derives d'indole, composition pharmaceutique les contenant et procede pour leur preparation
PT80111B (fr) Procede de preparation de nouveaux arylthio-pyridinyl-alcanole et de compositions fongicides les contenant
FR2601951B1 (fr) Nouvelles tetrahydrocarbazolones, composition pharmaceutique les contenant et leur procede de preparation
FR2528422B1 (fr) Nouveaux derives du 1,2,3,4-tetrahydronaphtalene, procede pour leur preparation et composition pharmaceutique contenant ces derives
MC1967A1 (fr) Compose b-lactamine,procede pour sa preparation,intermediaire pour sa synthese,et composition pharmaceutique le contenant,pour le traitement des maladies infectieuses d'origine bacterienne
FR2558828B1 (fr) " 1a,25-dihydroxy-22z-deshydrovitamine d " composition pharmaceutique et procede de preparation
BE884171A (fr) Nouveaux derives de l'ergol-8-ene et de l'ergoline, procede de preparation de ces derives et medicaments les contenant

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse